Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), National Peroxide has informed that a meeting of the Board of Directors of the company is scheduled to be held on Tuesday, February 14, 2023, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended on December 31, 2022.
The above information is a part of company’s filings submitted to BSE.